| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,020 |
15,898 |
$2.22M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,426 |
24,529 |
$1.89M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,711 |
4,025 |
$1.76M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
18,779 |
17,221 |
$1.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,976 |
4,281 |
$870K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,702 |
3,969 |
$843K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,536 |
34,796 |
$824K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,683 |
19,058 |
$682K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14,048 |
11,570 |
$599K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,161 |
5,525 |
$495K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,645 |
3,874 |
$486K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,763 |
3,354 |
$439K |
| 87428 |
|
4,548 |
4,084 |
$321K |
| 71045 |
Radiologic examination, chest; single view |
17,315 |
14,935 |
$313K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24,408 |
13,343 |
$304K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,446 |
5,829 |
$256K |
| 80053 |
Comprehensive metabolic panel |
38,435 |
33,362 |
$229K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,459 |
16,215 |
$210K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,129 |
33,320 |
$184K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,371 |
11,492 |
$173K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,073 |
7,847 |
$170K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,271 |
9,998 |
$158K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,336 |
1,086 |
$137K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
710 |
585 |
$130K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,930 |
4,189 |
$97K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,679 |
3,237 |
$83K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,562 |
3,229 |
$78K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15,628 |
11,452 |
$78K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
450 |
384 |
$75K |
| 84484 |
|
16,285 |
12,342 |
$73K |
| 71046 |
Radiologic examination, chest; 2 views |
1,961 |
1,769 |
$57K |
| 87081 |
|
7,672 |
7,194 |
$53K |
| 81001 |
|
24,342 |
21,034 |
$53K |
| 83690 |
|
12,066 |
10,508 |
$52K |
| J3490 |
Unclassified drugs |
21,108 |
8,077 |
$50K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
991 |
843 |
$47K |
| 36415 |
Collection of venous blood by venipuncture |
33,841 |
28,390 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,879 |
5,158 |
$44K |
| 82550 |
|
15,217 |
12,170 |
$44K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,887 |
3,785 |
$41K |
| 82553 |
|
8,750 |
6,998 |
$40K |
| 36000 |
|
3,721 |
3,265 |
$35K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,494 |
2,377 |
$34K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,356 |
1,230 |
$34K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,152 |
6,192 |
$32K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
360 |
324 |
$29K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
227 |
215 |
$27K |
| 80061 |
Lipid panel |
2,762 |
2,554 |
$23K |
| 83880 |
|
1,913 |
1,640 |
$21K |
| 84703 |
|
4,706 |
4,043 |
$20K |
| 87420 |
|
975 |
948 |
$19K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
258 |
233 |
$19K |
| 87807 |
|
1,423 |
1,244 |
$18K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
609 |
562 |
$18K |
| 83021 |
|
2,063 |
1,912 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,950 |
4,191 |
$14K |
| 99219 |
|
307 |
196 |
$12K |
| G0379 |
Direct admission of patient for hospital observation care |
91 |
75 |
$12K |
| A9270 |
Non-covered item or service |
24,820 |
7,331 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,377 |
4,868 |
$11K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
88 |
50 |
$10K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
210 |
179 |
$10K |
| 85379 |
|
1,936 |
1,687 |
$10K |
| Q3014 |
Telehealth originating site facility fee |
581 |
516 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
66 |
61 |
$9K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
285 |
73 |
$9K |
| 82248 |
|
3,143 |
2,791 |
$8K |
| 87040 |
|
1,758 |
845 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
205 |
189 |
$7K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
203 |
188 |
$6K |
| 81025 |
|
1,013 |
901 |
$6K |
| 96127 |
|
998 |
971 |
$6K |
| 59025 |
Fetal non-stress test |
112 |
68 |
$6K |
| 85027 |
|
1,435 |
1,169 |
$6K |
| 94760 |
|
561 |
497 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
124 |
117 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
25 |
25 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
222 |
175 |
$4K |
| 80055 |
|
155 |
145 |
$4K |
| 72100 |
|
177 |
148 |
$4K |
| 85730 |
|
2,193 |
1,841 |
$4K |
| 85610 |
|
2,794 |
2,274 |
$3K |
| 74022 |
|
57 |
54 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
20 |
13 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
484 |
469 |
$3K |
| G0378 |
Hospital observation service, per hour |
86 |
76 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
862 |
599 |
$3K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
12 |
$3K |
| 86703 |
|
210 |
197 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
104 |
97 |
$3K |
| 81003 |
|
2,679 |
2,281 |
$3K |
| 86787 |
|
169 |
158 |
$3K |
| 87077 |
|
1,746 |
1,477 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
154 |
148 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
708 |
435 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
704 |
515 |
$2K |
| 82607 |
|
312 |
284 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
24 |
20 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
28 |
24 |
$2K |
| 87186 |
|
836 |
677 |
$2K |
| 99406 |
|
325 |
271 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
113 |
108 |
$1K |
| 83735 |
|
470 |
356 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
198 |
188 |
$1K |
| 92587 |
|
29 |
26 |
$1K |
| 82803 |
|
406 |
310 |
$1K |
| 80305 |
|
112 |
100 |
$985.91 |
| 72110 |
|
20 |
18 |
$920.30 |
| 99215 |
Prolong outpt/office vis |
35 |
30 |
$913.82 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
13 |
$690.27 |
| 85018 |
|
207 |
187 |
$637.10 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
15 |
12 |
$633.94 |
| 87176 |
|
510 |
439 |
$600.99 |
| 86592 |
|
131 |
119 |
$580.15 |
| 96376 |
|
137 |
96 |
$496.79 |
| 82950 |
|
90 |
80 |
$456.96 |
| 84702 |
|
46 |
37 |
$444.25 |
| 72050 |
|
17 |
14 |
$310.21 |
| 69210 |
|
15 |
12 |
$268.36 |
| 73560 |
|
53 |
48 |
$250.81 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
411 |
360 |
$249.27 |
| 87071 |
|
15 |
12 |
$236.92 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
804 |
536 |
$231.50 |
| J2704 |
Injection, propofol, 10 mg |
185 |
144 |
$229.09 |
| 82150 |
|
60 |
52 |
$224.66 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
67 |
63 |
$208.76 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
425 |
330 |
$199.19 |
| 94664 |
|
12 |
12 |
$199.15 |
| 72070 |
|
16 |
13 |
$181.76 |
| 36600 |
|
212 |
165 |
$155.56 |
| 83540 |
|
30 |
27 |
$122.86 |
| 90686 |
|
2,342 |
2,179 |
$105.69 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
114 |
92 |
$101.21 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
75 |
66 |
$86.37 |
| 82962 |
|
72 |
48 |
$82.77 |
| 73630 |
|
12 |
12 |
$71.43 |
| 86900 |
|
17 |
15 |
$16.17 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
13 |
$12.66 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
511 |
306 |
$8.69 |
| 86850 |
|
17 |
14 |
$8.07 |
| 86901 |
|
18 |
15 |
$8.07 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
54 |
49 |
$6.32 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
107 |
77 |
$0.95 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
14 |
13 |
$0.00 |
| 90656 |
|
89 |
89 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
41 |
37 |
$0.00 |
| 76377 |
|
15 |
13 |
$0.00 |
| 91307 |
|
14 |
12 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
16 |
12 |
$0.00 |
| 90670 |
|
33 |
25 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
13 |
$0.00 |